These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6410375

  • 1. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo].
    Kochanova NK, Miakotina EN, Bellendir EN, Boiarkina SK, Iudelevich VI.
    Probl Tuberk; 1983 Jun; (6):65-8. PubMed ID: 6410375
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT.
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rifampicin activity "in vitro" and in established tuberculosis in mice.
    Verbist L.
    Acta Tuberc Pneumol Belg; 1969 Mar; 60(3):397-412. PubMed ID: 4984420
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Efficacy of rifampicin on experimental mouse tuberculosis].
    Yoshida F.
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):35-43. PubMed ID: 4990960
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Rifampicin resistence and virulence of M. tuberculosis for guinea pigs].
    Schröder KH, Koperska C.
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):112-3. PubMed ID: 4402403
    [No Abstract] [Full Text] [Related]

  • 12. [Pathomorphology of experimental tuberculosis induced by rifampicin-resistant mycobacteria].
    Vidin NB, El'shanskaia MP.
    Probl Tuberk; 1972 Jan; 50(7):63-7. PubMed ID: 4626207
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The advantages of the antituberculosis regimens which include Sinerdol-EH, a new tuberculostatic of rifampicin-type.
    Păunescu E.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983 Jan; 32(1):33-42. PubMed ID: 6312533
    [No Abstract] [Full Text] [Related]

  • 15. [Tuberculosis of hematopoietic organs in the child. 2 cases with pulmonary involvement].
    Caron M, Choulot JJ, Beaufils F, Aujard Y, Labrune B.
    Arch Fr Pediatr; 1978 Nov; 35(9):963-71. PubMed ID: 747504
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.